✦ LIBER ✦

JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia

✍ Scribed by Tono, C; Xu, G; Toki, T; Takahashi, Y; Sasaki, S; Terui, K; Ito, E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2 V617F mutation is a rare event in j

✍ Zecca, M; Bergamaschi, G; Kratz, C; Bergsträßer, E; Danesino, C; De Filippi, P; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

JAK2 V617F tyrosine kinase mutation in c

✍ Quentmeier, H; MacLeod, R A F; Zaborski, M; Drexler, H G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 276 KB

The prevalence of the activating JAK2 ty

✍ D. W. ORR; R. K. PATEL; N. C. LEA; R. H. WESTBROOK; J. G. O’GRADY; N. D. HEATON; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Presence of JAK2 V617F tyrosine kinase m

✍ Lea, N C; Lim, Z; Westwood, N B; Arno, M J; Gäken, J; Mohamedali, A; Mufti, G J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

JAK2-V617F activating mutation in acute

✍ Vicente, C; Vázquez, I; Marcotegui, N; Conchillo, A; Carranza, C; Rivell, G; Ban 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

JAK2-V617F activating mutation in acute

✍ Vicente, C; Vázquez, I; Marcotegui, N; Conchillo, A; Carranza, C; Rivell, G; Ban 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB